{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:14:47Z","timestamp":1792091687192,"version":"4.4.0"},"reference-count":42,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Nucleic Acid Therapeutics"],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:p>\n                    Cisplatin is an effective drug for treating various cancer types. However, it is highly toxic for both healthy and tumor cells. Therefore, there is a need to reduce its therapeutic dose and increase targeted bioavailability. One of the ways to achieve this could be the coating of cisplatin with polysaccharides and specific carriers for targeted delivery. Nucleic acid aptamers could be used as carriers for the specific delivery of medicine to cancer cells. Cisplatin-arabinogalactan-aptamer (Cis-AG-Ap) conjugate was synthesized based on Cis-dichlorodiammineplatinum, Siberian larch arabinogalactan, and aptamer AS-42 specific to heat-shock proteins (HSP) 71\u2009kDa (Hspa8) and HSP 90-beta (Hsp90ab1). The antitumor effect was estimated using ascites and metastatic Ehrlich tumor models. Cis-AG-Ap toxicity was assessed by blood biochemistry on healthy mice. Here, we demonstrated enhanced anticancer activity of Cis-AG-Ap and its specific accumulation in tumor foci. It was shown that targeted delivery allowed a 15-fold reduction in the therapeutic dose of cisplatin and its toxicity. Cis-AG-Ap sufficiently suppressed the growth of Ehrlich's ascites carcinoma, the mass and extent of tumor metastasis\n                    <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                    . Arabinogalactan and the aptamers promoted cisplatin efficiency by enhancing its bioavailability. The described strategy could be very promising for targeted anticancer therapy.\n                  <\/jats:p>","DOI":"10.1089\/nat.2022.0024","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:14:20Z","timestamp":1659525260000},"page":"497-506","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Nucleic Acid Aptamers Increase the Anticancer Efficiency and Reduce the Toxicity of Cisplatin-Arabinogalactan Conjugates\n                    <i>In Vivo<\/i>"],"prefix":"10.1177","volume":"32","author":[{"given":"Tatiana N.","family":"Zamay","sequence":"first","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Starkov","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Chemical Technology SB RAS, Federal Research Center \u201cKrasnoyarsk Science Center SB RAS,\u201d Krasnoyarsk, 660036, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga S.","family":"Kolovskaya","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina S.","family":"Zamay","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Veprintsev","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Luzan","sequence":"additional","affiliation":[{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena D.","family":"Nikolaeva","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill A.","family":"Lukyanenko","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."},{"name":"Department of Chemistry, Siberian Federal University, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina V.","family":"Artyushenko","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."},{"name":"Department of Chemistry, Siberian Federal University, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Shchugoreva","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."},{"name":"Department of Chemistry, Siberian Federal University, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury E.","family":"Glazyrin","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Koshmanova","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey V.","family":"Krat","sequence":"additional","affiliation":[{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariya S.","family":"Tereshina","sequence":"additional","affiliation":[{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey S.","family":"Zamay","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy S.","family":"Pats","sequence":"additional","affiliation":[{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan A.","family":"Zukov","sequence":"additional","affiliation":[{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix N.","family":"Tomilin","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Siberian Federal University, Krasnoyarsk, Russia."},{"name":"Laboratory for Physics of Magnetic Phenomena, Kirensky Institute of Physics, Federal Research Center Krasnoyarsk Science Center SB RAS, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim V.","family":"Berezovski","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-4629","authenticated-orcid":false,"given":"Anna S.","family":"Kichkailo","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Research Center\u201d of the Siberian Branch of the Russian Academy of Science, Krasnoyarsk, Russia."},{"name":"Laboratory For Biomolecular and Medical Technologies, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenecky, Krasnoyarsk, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"e_1_3_5_2_2","first-page":"3135","volume":"3","author":"Casini A","year":"2012","unstructured":"Casini A, and Reedijk J. (2012). Interactions of anticancer PT compounds with proteins: an overlooked topic in medicinal inorganic chemistry? Chem Sci, 3:3135\u20133144.","journal-title":"Interactions of anticancer PT compounds with proteins: an overlooked topic in medicinal inorganic chemistry? Chem Sci"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1351\/PAC-CON-10-11-03"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2167"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1691"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.07.025"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.05.022"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2006.09.006"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1253"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810301)47:5<857::AID-CNCR2820470508>3.0.CO;2-M"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.162491399"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809154105"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011379108"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02039-w"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/14686996.2019.1590126"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-016-0086-x"},{"key":"e_1_3_5_17_2","first-page":"96","article-title":"Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide","volume":"4","author":"Kelly GS","year":"1999","unstructured":"Kelly GS. (1999). Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Altern Med Rev, 4:96\u2013103.","journal-title":"Altern Med Rev"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/bm900853z"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1134\/S1607672916020046"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1134\/S1990747820010092"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1134\/S1990747813050061"},{"key":"e_1_3_5_22_2","unstructured":"Starkov AK Pavlenko NI and Kozhukhovskaja. GA (2019). Method of obtaining drug based on Cis-diamine(cyclobutane-1 1-dicarboxylateo o\u2019)platinum(ii) interaction with arabinogalactan. RU2679136C1."},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.08.007"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010216"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.02.013"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2015.1075688"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2013.0471"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.11647"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2003.10.015"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929866521666140626102429"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.10.5767"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2017.06.002"},{"key":"e_1_3_5_33_2","first-page":"114","article-title":"Lost in translation: animal models and clinical trials in cancer treatment","volume":"6","author":"Mak IW","year":"2014","unstructured":"Mak IW, , Evaniew N, and Ghert M. (2014). Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res, 6:114\u2013118.","journal-title":"Am J Transl Res"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.06.020"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-8838(09)00201-3"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr020010d"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00244-7"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80430-4"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/79102"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.01.017"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2004.04127.x"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160819836"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr980421n"}],"container-title":["Nucleic Acid Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/nat.2022.0024","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/nat.2022.0024","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/nat.2022.0024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:02:44Z","timestamp":1777669364000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/nat.2022.0024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12,1]]}},"alternative-id":["10.1089\/nat.2022.0024"],"URL":"https:\/\/doi.org\/10.1089\/nat.2022.0024","relation":{},"ISSN":["2159-3337","2159-3345"],"issn-type":[{"value":"2159-3337","type":"print"},{"value":"2159-3345","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}